Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

17:38 ET Seattle Pharmacy Group Wins National Award for Innovation and Collaboration in Healthcare

 The nation's oldest and largest national professional society of pharmacists recently announced that Seattle's Kelley-Ross Pharmacy Group was...


17:00 ET PharmAthene Withdraws Protest Against HHS Over Anthrax Vaccine Bidding Process

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that after discussions...


15:34 ET EpiBiome Selected to Present at KC Animal Health Investment Forum

 EpiBiome, a precision microbiome engineering company, has been selected to participate in the KC Animal Health Investment Forum. The company...


15:27 ET Mylan's Adoption of the Valeant-Turing 'Blame the Victim' Strategy Will Not Pass the Laugh Test in Washington

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on Mylan's EpiPen price hikes and...


14:51 ET Vanda Patents Found Valid and Infringed in Fanapt® ANDA Litigation

 Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that Judge Gregory M. Sleet of the United States District Court for the...


11:29 ET Upsher-Smith Enters Into Exclusive Marketing and Distribution Agreement with Emerging Pharmaceutical Company

 Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has entered into an exclusive agreement with an emerging pharmaceutical...


09:15 ET Alexander Nachman, America's Leading Cannabis Advocate, Writes "The Golden Calf: A Modern Day Tale of Lies and Corruption, and Our Nation's Fall From Grace"

 Alexander Nachman, America's "Pitbull of Pot" and expert on the cannabis industry, wrote about the hypocrisy of the United States Government's...


09:00 ET Boehringer Ingelheim and Duke Clinical Research Institute Expand Collaboration to Create Largest Patient Registry for Idiopathic Pulmonary Fibrosis (IPF)

Boehringer Ingelheim Pharmaceuticals, Inc. and the Duke Clinical Research Institute (DCRI) announced today the expansion of the Idiopathic...


08:45 ET Essential Pharmaceuticals CSO Dr. Adam Elhofy Publishes New Data on Cell-Ess® Universal Titer Boost and Enhancer

 Essential Pharmaceuticals, LLC Chief Science Officer, Dr. Adam Elhofy, has published new data on Cell-Ess® universal titer boost and...


08:30 ET New InfoRx Mobile App from Vivacare Helps Medical Professionals Deliver an Information Prescription to Educate and Engage Patients

 Vivacare (www.vivacare.com) today announced the release of the latest version of its InfoRx patient engagement app that enables medical...


08:05 ET Aytu BioScience to Provide Fiscal Fourth Quarter and Fiscal 2016 Business Update

 Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of...


08:00 ET Zoned Properties Announces Expansion of Leased Facilities at Medical Marijuana Business Park in Tempe, Arizona

 Zoned Properties, Inc. (OTCQX: ZDPY), a strategic real estate development firm whose primary mission is to identify, develop, and lease...


08:00 ET Teligent, Inc. Announces Health Canada Approval Of Three Baclofen Injection Products

 Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that its Estonian subsidiary,...


08:00 ET Crown Bioscience Expands CVMD Leadership Team

 Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic...


08:00 ET Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

 Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced results...


08:00 ET Crown Bioscience étend son équipe de direction MCVM

 Crown Bioscience, société internationale de services de découverte et de développement de médicaments proposant des...


08:00 ET Crown Bioscience erweitert CVMD-Führungsteam

 Crown Bioscience, ein globales Serviceunternehmen für die Arzneimittelforschung und -entwicklung, das translationale Plattformen zur...


07:30 ET Drug Makers Stocks under Review -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline

Stock-Callers.com has initiated research reports on the following Major Drug Manufacturers in the Healthcare sector: Bristol-Myers Squibb Co....


07:30 ET Mallinckrodt Receives FDA Fast-Track Designation for Synacthen® Depot IND Application

 Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA)...


07:10 ET Company Pipeline Analysis and Sales Projections for the Top 25 Pharmaceutical Companies 2016-2025 - Research and Markets

Research and Markets has announced the addition of the "Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025" report to...


07:00 ET BioLineRx and I-Bridge Capital Establish a New Drug Development Joint Venture in China

BioLineRx Ltd. (NASDAQ/TASE:BLRX), a clinical stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising...


07:00 ET NanoViricides Reports on Senator Murphy's Visit to the Company's Shelton Campus

 NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a global leader in nanomedicines that is developing biomimetic anti-viral drugs reports...


07:00 ET Mylan Taking Immediate Action to Further Enhance Access to EpiPen® (Epinephrine Injection, USP) Auto-Injector

Mylan N.V. (NASDAQ, TASE: MYL) today announced it is taking immediate action to further enhance access to EpiPen® (epinephrine injection, USP)...


06:30 ET Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Trastuzumab Accepted for Review by European Medicines Agency

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced today that the European Medicines Agency (EMA) has...


06:00 ET AANEM, in Coordination With Critical Thinking Co., Develops Exam to Assess Clinical Knowledge of Non-Clinicians

 Critical Thinking Co. (CTC), a life sciences-focused sales consulting, education, and development firm, and the American Association of...